Omnicell Number of Employees 2010-2023 | OMCL

Omnicell number of employees from 2010 to 2023. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
Omnicell Annual Employee Count
2023 3,650
2022 4,230
2021 3,800
2020 2,860
2019 2,700
2018 2,480
2017 2,350
2016 2,444
2015 1,451
2014 1,236
2013 1,134
2012 1,089
2011 773
2010 753
2009 753
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.278B $1.147B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $38.555B 21.44
Inspire Medical Systems (INSP) United States $6.945B 0.00
IRhythm Technologies (IRTC) United States $3.488B 0.00
Axonics (AXNX) United States $3.415B 0.00
10x Genomics (TXG) United States $3.330B 0.00
Enovis (ENOV) United States $3.062B 23.26
Azenta (AZTA) United States $2.825B 230.23
Olink Holding AB (publ) (OLK) Sweden $2.719B 0.00
Hims & Hers Health (HIMS) United States $2.550B 0.00
Privia Health (PRVA) United States $2.145B 95.16
Schrodinger (SDGR) United States $1.756B 0.00
Phreesia (PHR) United States $1.224B 0.00
Definitive Healthcare (DH) United States $0.832B 0.00
Standard BioTools (LAB) United States $0.731B 0.00
Fulgent Genetics (FLGT) United States $0.609B 0.00
Talkspace (TALK) United States $0.530B 0.00
Health Catalyst (HCAT) United States $0.327B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.324B 0.00
Clover Health Investments (CLOV) United States $0.315B 0.00
Pulmonx (LUNG) United States $0.289B 0.00
P3 Health Partners (PIII) United States $0.160B 0.00
Butterfly Network (BFLY) United States $0.159B 0.00
American Well (AMWL) United States $0.158B 0.00
Augmedix (AUGX) United States $0.146B 0.00
MSP Recovery (LIFW) United States $0.133B 0.00
TruBridge (TBRG) United States $0.121B 5.17
Outset Medical (OM) United States $0.120B 0.00
111 (YI) China $0.085B 0.00
SHL Telemedicine (SHLT) Israel $0.076B 0.00
Future Health ESG (FHLT) United States $0.064B 0.00
Zepp Health (ZEPP) China $0.051B 0.00
HeartBeam (BEAT) United States $0.051B 0.00
EUDA Health Holdings (EUDA) Singapore $0.043B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Movano (MOVE) United States $0.027B 0.00
Cue Health (HLTH) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.019B 0.00
Akili (AKLI) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Centogene (CNTG) Germany $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00